![](/img/cover-not-exists.png)
Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myeloma
Moreau, P, Cavallo, F, Leleu, X, Hulin, C, Amiot, M, Descamps, G, Facon, T, Boccadoro, M, Mignard, D, Harousseau, J LVolume:
25
Language:
english
Journal:
Leukemia
DOI:
10.1038/leu.2011.4
Date:
May, 2011
File:
PDF, 199 KB
english, 2011